The controversial laboratory tool known as CRISPR may have found a whole new world to conquer. Already the favored method of editing genes, CRISPR could soon become a low-cost diagnostic tool that could be used practically anywhere to determine if someone has an infectious disease such as Zika or dengue.
The controversial gene-editing tool may be able to identify infections reliably for pennies in places without electricity.
Toyota is introducing a wearable robotic leg brace designed to help partially paralyzed people walk.
The Welwalk WW-1000 system is made up of a motorized mechanical frame that fits on a person’s leg from the knee down. The patients can practice walking wearing the robotic device on a special treadmill that can support their weight.
Toyota Motor Corp. demonstrated the equipment for reporters at its Tokyo headquarters on Wednesday.
Oscar Wilde once said that life imitates art, and science and engineering is often no exception to this. Science fiction certainly provides science types with plenty of inspiration for inventions, including holograms, teleportation, and even sonic screwdrivers.
Star Trek’s all-purpose medical device, the Tricorder, has also inspired a fair few people to recreate its near-magical ability to instantly diagnose a patient. As it happens, the non-profit X-Prize Foundation were so keen to get one invented that they started a global competition to see if any mavericks would succeed.
Rather remarkably, one team has emerged victorious in their endeavor. A family-led team from Pennsylvania, appropriately named Final Frontier Medical Devices, have bagged themselves a sum of $2.5 million, with a second-place prize of $1 million going to the Taiwan-based Dynamical Biomarkers Group.
This contains information that is not in other articles on the same topic of David Sinclair:
“The results certainly sound encouraging. Before he started taking a 500mg NMN pill every morning, 47-year-old Professor Sinclair had his blood tested and was told his body had a biological age of 58.
After consuming NMN for three months, he was tested again and his biological age was 32.”
A proton beam can kill cancer cells, and the accelerators used for treatment are always the circular kind. Linear accelerators (“linacs”) allow more control of the beam; for example, the energy can be varied rapidly to match a patient’s breathing. But linacs take up a lot of space. Now researchers propose a design that could fit in a room 10 m x 20 m, potentially making linacs practical for patient therapy. Research from CERN.
While many scientists have shied away from explicitly political actions in recent decades, the community throughout history has spoken publicly on a wide variety of social, technological and ideological issues.
That has included everything from opposing fascism, nuclear proliferation and the Vietnam War to sitting on government panels that advise elected leaders on stem-cell research involving human embryos.
In U.S. history, scientists have been vocal about fascism, nuclear proliferation, the Vietnam War, stem cells and more.
Many artificial organs are being developed as an alternative to donated organs, which are only temporary solutions that require the recipients to maintain a lifetime regiment of medications. With recent advancements in biomedical technologies, the time may be coming when those who require transplants no longer need to wait on donation lists to replace organs like kidneys and blood vessels. And now, scientists have added the thymus to the list of body parts we can artificially simulate.
The thymus is a gland that is essential to your immune system. T cells, a type of white blood cell that helps to get rid of viruses, bacterial infections, and cancer cells, mature within this gland. When people get sick (or as they age), the thymus becomes worse at its job. In some cases, people with different types of cancer are not getting the biological support and help they need from their T cells.
A team of Australian researchers have discovered a new method to fight colon and stomach cancer. Their technique involves inhibiting a protein that cancer cells use to rapidly reproduce.
“Our discovery could potentially offer a new and complementary approach to chemotherapy and immunotherapy as options for treating gastrointestinal cancers,” said professor Matthias Ernst, scientific director at the Olivia Newton-John Cancer Research Institute, in a statement.
Hematopoietic cell kinase (HCK) is an enzyme that helps stem cells become blood cells – hematopoietic cells are the stem cells that all blood cells start as. One type of blood cells that HCK helps to code are macrophages, “big eater” white blood cells whose job is to consume and destroy anything that impedes healthy blood, such as cellular debris, microbes and cancer cells.
